PacBio to Present at Upcoming Investor Conferences
PacBio (NASDAQ: PACB), a developer of high-quality sequencing solutions, has announced its participation in two major upcoming investor conferences. The company will present at the Jefferies Global Healthcare Conference on June 5, 2025, at 8:45 AM ET in New York, and at the 46th Annual Goldman Sachs Global Healthcare Conference on June 11, 2025, at 10:40 AM ET in Miami Beach. Both presentations will be available via live webcasts on PacBio's investor relations website, with replays accessible for at least 30 days after each event.
PacBio (NASDAQ: PACB), sviluppatore di soluzioni di sequenziamento di alta qualità, ha annunciato la sua partecipazione a due importanti conferenze per investitori in programma. L'azienda presenterà al Jefferies Global Healthcare Conference il 5 giugno 2025 alle 8:45 ET a New York, e al 46° Annual Goldman Sachs Global Healthcare Conference l'11 giugno 2025 alle 10:40 ET a Miami Beach. Entrambe le presentazioni saranno disponibili in diretta streaming sul sito web delle relazioni con gli investitori di PacBio, con le repliche accessibili per almeno 30 giorni dopo ogni evento.
PacBio (NASDAQ: PACB), desarrollador de soluciones de secuenciación de alta calidad, ha anunciado su participación en dos importantes conferencias para inversores próximas. La compañía presentará en la Jefferies Global Healthcare Conference el 5 de junio de 2025 a las 8:45 AM ET en Nueva York, y en la 46ª Conferencia Anual Global de Salud de Goldman Sachs el 11 de junio de 2025 a las 10:40 AM ET en Miami Beach. Ambas presentaciones estarán disponibles mediante transmisiones en vivo en el sitio web de relaciones con inversores de PacBio, con repeticiones accesibles durante al menos 30 días después de cada evento.
PacBio (NASDAQ: PACB)는 고품질 시퀀싱 솔루션 개발업체로, 다가오는 두 주요 투자자 컨퍼런스에 참여할 것임을 발표했습니다. 회사는 2025년 6월 5일 오전 8시 45분(동부시간) 뉴욕에서 열리는 Jefferies Global Healthcare Conference와 2025년 6월 11일 오전 10시 40분(동부시간) 마이애미 비치에서 열리는 제46회 연례 골드만 삭스 글로벌 헬스케어 컨퍼런스에서 발표할 예정입니다. 두 발표 모두 PacBio 투자자 관계 웹사이트를 통해 생중계되며, 각 행사 후 최소 30일간 다시보기 서비스를 이용할 수 있습니다.
PacBio (NASDAQ : PACB), développeur de solutions de séquençage de haute qualité, a annoncé sa participation à deux grandes conférences investisseurs à venir. La société présentera lors de la Jefferies Global Healthcare Conference le 5 juin 2025 à 8h45 ET à New York, ainsi qu'à la 46e conférence annuelle Goldman Sachs Global Healthcare le 11 juin 2025 à 10h40 ET à Miami Beach. Les deux présentations seront disponibles en webdiffusion en direct sur le site des relations investisseurs de PacBio, avec des rediffusions accessibles pendant au moins 30 jours après chaque événement.
PacBio (NASDAQ: PACB), ein Entwickler hochwertiger Sequenzierungslösungen, hat seine Teilnahme an zwei wichtigen bevorstehenden Investorenkonferenzen bekannt gegeben. Das Unternehmen wird auf der Jefferies Global Healthcare Conference am 5. Juni 2025 um 8:45 Uhr ET in New York sowie auf der 46. jährlichen Goldman Sachs Global Healthcare Conference am 11. Juni 2025 um 10:40 Uhr ET in Miami Beach präsentieren. Beide Präsentationen werden live auf der Investor-Relations-Website von PacBio übertragen, wobei Wiedergaben mindestens 30 Tage nach jeder Veranstaltung verfügbar sind.
- None.
- None.
MENLO PARK, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that management will be participating in the following upcoming investor conferences:
- Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 8:45 AM ET in New York, NY
- 46th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 11, 2025, at 10:40 AM ET in Miami Beach, FL
Live webcasts of the events can be accessed at the company’s investors page at investor.pacificbiosciences.com. A replay of the webcasts will be available for at least 30 days following the event.
About PacBio
PacBio (NASDAQ: PACB) is a premier life science technology company that designs, develops, and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technologies, which include our HiFi long-read sequencing, address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for Research Use Only. Not for use in diagnostic procedures.
Contacts
Investors:
Todd Friedman
ir@pacb.com
Media:
pr@pacb.com
FAQ
When is PacBio (PACB) presenting at the Jefferies Global Healthcare Conference 2025?
Where can I watch PacBio's (PACB) investor conference presentations?
What time is PacBio's (PACB) presentation at the Goldman Sachs Healthcare Conference 2025?
Which investor conferences is PacBio (PACB) attending in June 2025?
